Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 196

1.

Expression of peroxisome proliferator-activated receptor gamma in salivary duct carcinoma: immunohistochemical analysis of 15 cases.

Mukunyadzi P, Ai L, Portilla D, Barnes EL, Fan CY.

Mod Pathol. 2003 Dec;16(12):1218-23.

PMID:
14681322
[PubMed - indexed for MEDLINE]
Free Article
2.

Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.

Begum NM, Nakashiro K, Kawamata H, Uchida D, Shintani S, Ikawa Y, Sato M, Hamakawa H.

Int J Oncol. 2002 Mar;20(3):599-605.

PMID:
11836575
[PubMed - indexed for MEDLINE]
3.

Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases.

Simpson RH, Prasad AR, Lewis JE, Skálová A, David L.

Am J Surg Pathol. 2003 Aug;27(8):1070-9.

PMID:
12883239
[PubMed - indexed for MEDLINE]
4.

Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma.

Kapadia SB, Barnes L.

Mod Pathol. 1998 Nov;11(11):1033-8.

PMID:
9831198
[PubMed - indexed for MEDLINE]
5.
6.

Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.

Yamamoto H, Uryu H, Segawa Y, Tsuneyoshi M.

Pathol Int. 2008 May;58(5):322-6. doi: 10.1111/j.1440-1827.2008.02231.x.

PMID:
18429833
[PubMed - indexed for MEDLINE]
7.

Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.

Galusca B, Dumollard JM, Chambonniere ML, Germain N, Prades JM, Péoc'h M, Estour B.

Anticancer Res. 2004 May-Jun;24(3b):1993-7.

PMID:
15274390
[PubMed - indexed for MEDLINE]
Free Article
8.

Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.

Jung TI, Baek WK, Suh SI, Jang BC, Song DK, Bae JH, Kwon KY, Bae JH, Cha SD, Bae I, Cho CH.

Gynecol Oncol. 2005 May;97(2):365-73.

PMID:
15863131
[PubMed - indexed for MEDLINE]
9.

Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARgamma) in human neuroblastoma cells.

Han SW, Greene ME, Pitts J, Wada RK, Sidell N.

Clin Cancer Res. 2001 Jan;7(1):98-104.

PMID:
11205925
[PubMed - indexed for MEDLINE]
Free Article
10.

Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.

Han S, Sidell N, Fisher PB, Roman J.

Clin Cancer Res. 2004 Mar 15;10(6):1911-9.

PMID:
15041706
[PubMed - indexed for MEDLINE]
Free Article
11.

Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.

Williams MD, Roberts D, Blumenschein GR Jr, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK.

Am J Surg Pathol. 2007 Nov;31(11):1645-52.

PMID:
18059220
[PubMed - indexed for MEDLINE]
12.

Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.

Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T.

Cancer. 2005 Jun 15;103(12):2526-33.

PMID:
15900577
[PubMed - indexed for MEDLINE]
Free Article
13.

Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma.

Ota K, Ito K, Suzuki T, Saito S, Tamura M, Hayashi S, Okamura K, Sasano H, Yaegashi N.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4200-8.

PMID:
16857792
[PubMed - indexed for MEDLINE]
Free Article
14.

Expression of the adenocarcinoma-related antigen recognized by monoclonal antibody 44-3A6 in salivary gland neoplasias.

Bentz BG, Haines GK 3rd, vonSchlegell AS, Elseth KM, Hanson DG, Radosevich JA.

Otolaryngol Head Neck Surg. 1998 May;118(5):603-9.

PMID:
9591857
[PubMed - indexed for MEDLINE]
15.

Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptor gamma.

Nakashiro K, Begum NM, Uchida D, Kawamata H, Shintani S, Sato M, Hamakawa H.

Oral Oncol. 2003 Dec;39(8):855-61.

PMID:
13679209
[PubMed - indexed for MEDLINE]
16.

Peroxisome proliferator-activated receptor gamma in human prostate carcinoma.

Nakamura Y, Suzuki T, Sugawara A, Arai Y, Sasano H.

Pathol Int. 2009 May;59(5):288-93. doi: 10.1111/j.1440-1827.2009.02367.x.

PMID:
19432669
[PubMed - indexed for MEDLINE]
17.

Low-grade salivary duct carcinoma: description of 16 cases.

Brandwein-Gensler M, Hille J, Wang BY, Urken M, Gordon R, Wang LJ, Simpson JR, Simpson RH, Gnepp DR.

Am J Surg Pathol. 2004 Aug;28(8):1040-4.

PMID:
15252310
[PubMed - indexed for MEDLINE]
18.

Salivary duct carcinoma cytologically diagnosed distinctly from salivary gland carcinomas with squamous differentiation.

Kawahara A, Harada H, Akiba J, Kage M.

Diagn Cytopathol. 2008 Jul;36(7):485-93. doi: 10.1002/dc.20823.

PMID:
18528886
[PubMed - indexed for MEDLINE]
19.

Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.

He Q, Chen J, Lin HL, Hu PJ, Chen MH.

Chin Med J (Engl). 2007 Sep 5;120(17):1498-504.

PMID:
17908458
[PubMed - indexed for MEDLINE]
20.

Intraoral salivary duct carcinoma: case report with immunohistochemical observations.

Lopes MA, de Abreu Alves F, Levy BA, de Almeida OP, Kowalski LP.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):689-92.

PMID:
11402284
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk